Fierce Pharma

APRIL 27, 2023

Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says kdunleavy Thu, 04/27/2023 - 15:08

Patients 264

Patients 264

PM360

MAY 15, 2023

For nine years, we have looked to recognize those people in healthcare and life sciences who are making a mark on our industry, on patients, on colleagues, on the world. Master Educators: People who revolutionize the way patients/doctors learn and absorb information. Make a mark on the world that can’t be erased.”

Education 105

Education Media Marketing Sales 105

Fierce Pharma

APRIL 14, 2023

AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin aliu Fri, 04/14/2023 - 22:19

Patients 215

Patients 215

Fierce Pharma

MARCH 17, 2023

Astellas, Pfizer look to broaden Xtandi’s patient base with new prostate cancer win after 8 years aliu Fri, 03/17/2023 - 10:22

Patients 231

Patients 231

Fierce Pharma

MAY 16, 2023

BeiGene, Max Foundation team up to provide free Brukinsa to CLL patients in 29 low-income countries aliu Tue, 05/16/2023 - 15:35

Patients 200

Patients 200

European Pharmaceutical Review

JANUARY 29, 2024

N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. 4 The use of CPCA assessments allows for the assignment of scientifically justifiable higher acceptable intakes (AIs), without impacting patient safety.

Pharmaceutical 99

Pharmaceutical Food and Drug Administration Medicine FDA 99

Fierce Pharma

MARCH 6, 2023

ACC23: Bayer and J&J's Xarelto reduces ischemia risk for PAD patients after revascularization surgery kdunleavy Mon, 03/06/2023 - 07:09

Patients 188

Patients 188

Fierce Pharma

MARCH 6, 2023

ACC23: J&J's combo pill of Opsumit plus tadalafil improves blood flow in PAH patients kdunleavy Mon, 03/06/2023 - 08:29

Patients 198

Patients 198

PM360

NOVEMBER 2, 2023

Nuvera Life Science Consulting is pleased to announce its third annual awards for the pharmaceutical companies designated as “best-in-class” in patient support and access by physicians and support staff surveyed for the company’s 2023 PURE Reports : Bristol Myers Squibb in oncology and Genentech in neurology.

Pharmaceutical 52

Pharmaceutical Patients Physicians Consulting 52

Impetus Digital

JANUARY 13, 2023

Patient-centricity taking center stage. In 2023, “hybrid” will mean two different things to different people: a) an in-person meeting with a live virtual component (i.e., In the near future, we will see a broad expansion of medical engagement across providers, patients, and other stakeholders. Let’s dive in!

Pharma 109

Pharma Medical Patients Healthcare 109

European Pharmaceutical Review

DECEMBER 11, 2023

Results from MaaT Pharma’s Early Access Program (EAP) for its microbiome-based therapy MaaT013, have demonstrated positive overall response and overall survival rates in European patients with graft-versus-host disease (GvHD). The findings were presented at the 2023 American Society of Hematology (ASH) Annual Meeting.

Patients 115

Patients Pharma Pharmaceutical 115

Fierce Pharma

APRIL 26, 2023

FDA argues AstraZeneca, Merck's Lynparza only works in subset of prostate cancer patients aliu Wed, 04/26/2023 - 14:19

FDA 146

FDA Patients 146

Fierce Pharma

FEBRUARY 24, 2023

J&J wins EU backing for PARP combo Akeega in prostate cancer—but only in some patients aliu Fri, 02/24/2023 - 12:07

Patients 187

Patients 187

MedCity News

FEBRUARY 2, 2023

The percentage of respondents who know of a patient death being caused by nurses being assigned too many patients nearly doubled in the past seven years — from 22% in 2016 to 42% in 2023.

Patients 128

Patients Safety 128

European Pharmaceutical Review

MAY 29, 2023

A neurosteroid drug was one of two medicines recommended for approval at the Committee for Medicinal Products for Human Use (CHMP) ’s May 2023 meeting. This medicinal product has potential to diagnose this cancer in high risk patients in early stages and for patients with suspected recurrence.

Medicine 92

Medicine Marketing Safety Leads 92

Fierce Pharma

MARCH 27, 2023

Discussing the rise of patient-centricity in life sciences jpiatt Mon, 03/27/2023 - 14:49

Patients 130

Patients 130

PM360

SEPTEMBER 7, 2023

However, Keri McDonough, Head, Patient Voice Consortium & Vice President, Medical and Scientific Strategy, Syneos Health , says that AI will only help so much in alleviating the “ burnout ” 3 or “ moral injury ” 4 many HCPs face. “To Of course, AI can also be used to help marketers better understand and serve patients.

Patients 111

Patients Physicians Healthcare Healthcare 111

European Pharmaceutical Review

OCTOBER 10, 2023

Patients were 1.21 percent of patients treated with the nasal spray formulation of esketamine reported a TEAE that resolved same day. percent of quetiapine XR patients. percent of esketamine nasal spray-treated patients who reported a TEAE that persisted for more than one day, versus 74.7 However, 82.6 There were 53.6

Safety 89

Safety Leads Patients Pharmaceutical 89

Fierce Pharma

MARCH 2, 2023

Harnessing Data to Improve Patient Access And Optimize Gross-to-Net jpiatt Thu, 03/02/2023 - 14:47

Patients 130

Patients 130

pharmaphorum

NOVEMBER 6, 2023

UK patient data project reaches one million volunteers Phil.Taylor Mon, 06/11/2023 - 08:55 Bookmark this

Patients 104

Patients 104

Clarivate

SEPTEMBER 19, 2023

The Citation Laureates 2023 list has been announced, recognizing a select group of influential, highly cited researchers whose contributions are on par with Nobel Prize recipients. The impact on our world Citation Laureates 2023 have reshaped the boundaries of human knowledge, pushing the frontiers of what is known and what is possible.

Electronics 111

Electronics Medicine Government Patients 111

European Pharmaceutical Review

OCTOBER 23, 2023

An intravesical drug delivery system designed to provide sustained local release of gemcitabine into the bladder, has enabled 77 percent of bladder cancer patients (23 out of 30) to achieve a complete response (CR) in the Cohort 2 of the Phase IIb SunRISe-1 study. Sanofi-Janssen collaboration to advance novel E.

Pharmaceutical 97

Pharmaceutical Safety Patients Leads 97

pharmaphorum

DECEMBER 1, 2023

MSD, Amgen back patient data specialist Culmination Bio Phil.Taylor Fri, 01/12/2023 - 11:40 Bookmark this

Patients 97

Patients 97

PharmaTech

SEPTEMBER 19, 2023

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses the definition of patient safety and how to implement new technologies into upgraded facilities.

Safety 98

Safety Patients Consulting FDA 98

PharmExec

MAY 4, 2023

Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement.

Patients 64

Patients Pharma Networking Medical 64

MedCity News

MARCH 13, 2023

Each year, nonprofit ECRI creates a list of the industry’s top ten patient safety concerns. This year, the pediatric mental health crisis topped the list, above other important issues like violence against healthcare staff and clinicians being expected to work outside their scope of practice.

Safety 96

Safety Patients Healthcare Healthcare 96

Healthcare Success

DECEMBER 6, 2022

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Patients Consumers are researching online, and their searches are becoming more sophisticated. Consumer-First Content is Essential.

Healthcare 112

Healthcare Healthcare Marketing Competition 112

European Pharmaceutical Review

JUNE 30, 2023

The power of rapid methods for fungal ID By leveraging rapid identification techniques, pharmaceutical facilities can enhance their ability to detect and mitigate fungal contamination, safeguarding product quality and patient safety. The post In Depth Focus QA/QC Microbiology/RMM 2023 appeared first on European Pharmaceutical Review.

Safety 105

Safety Pharmaceutical Patients 105

European Pharmaceutical Review

OCTOBER 25, 2023

CPHI Barcelona has announced the winners of 2023 CPHI Pharma Awards. A wearable patch that uses ultrasounds to deliver drugs subcutaneously, removes the need for needles and cannulas, creating a unique drug delivery system that ensures patient comfort.

Pharma 93

Pharma Manufacturing Management Pharmaceutical 93

MedCity News

JUNE 15, 2023

Now that Medicaid redeterminations have resumed, Walgreens is supporting patients by educating them about renewals and helping them navigate through the process, execs said at AHIP 2023 in Portland.

Patients 98

Patients Education 98

pharmaphorum

DECEMBER 20, 2023

FDA OKs test to spot patients at risk of opioid use disorder Phil.Taylor Wed, 20/12/2023 - 10:14 Bookmark this

FDA 101

FDA Patients 101

pharmaphorum

NOVEMBER 24, 2023

International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.Raleigh Fri, 24/11/2023 - 11:24 Bookmark this

Pharma 88

Pharma Patients 88

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). And in 2023, these investments will hopefully pay off. They’ve laid the necessary groundwork for cross-functional visibility, collaboration, and connectivity.

Marketing 90

Marketing Sales Medical Patients 90

Pharmaceutical Technology

JUNE 5, 2023

Results unveiled at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting indicate that some patients with locally advanced rectal cancer can be treated with chemotherapy alone and may not need radiation therapy before surgery. Additionally, the patients had to be candidates for surgery. In the FOLFOX group, 9.1%

Patients 52

Patients Side effects Medicine 52

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA with the theme, “Impacting Innovation, Value, and Healthcare Decision Making.”

Electronics 97

Electronics Healthcare Healthcare Healthcare Provider 97

MedCity News

MAY 7, 2023

To positively impact the health of the most significant number of people, dentistry must be amplified by AI and truly become preventive care.

Patients 110

Patients 110

Pharmaceutical Commerce

DECEMBER 11, 2023

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

Patients 105

Patients 105